About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us
 

Welcome to DAXOR Corporation!

 
 

11/17/2014 - Daxor Corporation Announces Payment of a Dividend

  

11/3/2014 - Daxor Announces Publication of a Study Comparing Two Widely Used Surrogate Tests for Estimating Blood Volume with Direct Measurement of Blood Volume

  

10/21/2014 - Daxor Corporation Announces Research Agreement with Virginia Commonwealth University on Burn Patients

  
 

______________________

 
     
  Form N-CSR for Jun 30, 2014  
  Form N-Q for Mar 31, 2014  
  Form NSAR-B for Dec 31, 2013  
  Form N-Q for Sep 30, 2013  
 

DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility.


The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.

 

Find out more about the BVA-100 >

 

See where blood volume tests are being performed >

 

Watch San Antonio's KENS5 station feature on the BVA-100
(MPEG video; 19 MB) >


 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806


© 2014 DAXOR Corporation. All Rights Reserved.